- Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy2020 | Lékařská fakulta v Hradci Králové
- In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase2024 | Lékařská fakulta v Hradci Králové
- Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)2023 | Publikace bez příslušnosti k fakultě